Clinical trial Recruiting at 1 site Observational Ages 13 to 80

Checking thyroid function in adults on hemodialysis at Sohag University Hospital

Official title: Assessment of Thyroid Dysfunction in Patients Undergoing Haemodialysis at Sohag University Hospital

Run by Sohag University · NCT07022236 · Data updated 2026-11-12

This project tests whether routine thyroid blood tests find thyroid problems in adults who have been on regular hemodialysis for at least three months.

Quick facts

Study typeObservational
Ages13 Years to 80 Years
SexAll
Enrollment1 (estimated)
SponsorSohag University
Academic / other
Locations1 site (Sohag)
StatusRecruiting
StartedApril 13, 2025
Main results expectedOctober 13, 2025
Study endsOctober 30, 2025
Registry record updatedJune 15, 2025
Trial IDNCT07022236 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with end-stage renal disease who have been on regular hemodialysis for at least three months and who do not have a prior history of thyroid disease or recent thyroid treatment are ideal candidates.

Probably not a fit

Patients with known thyroid disorders, recent thyroid treatment, acute kidney injury, pregnancy or lactation, or who are taking medications that interfere with thyroid tests are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will measure thyroid function (typical thyroid profile tests such as TSH, free T4, and free T3) in adults with end-stage renal disease receiving regular hemodialysis at Sohag University Hospital. Patients with prior thyroid disease, recent thyroid treatment, acute kidney injury, pregnancy, or medications known to affect thyroid tests are excluded. Results will be analyzed for the prevalence of thyroid dysfunction and correlations with clinical factors such as dialysis duration and comorbidities. The study involves blood sampling during routine clinic visits and does not introduce experimental treatments.

Why it matters

Potential benefit: If successful, the findings could support more routine thyroid screening for people on long-term hemodialysis, enabling earlier detection and management of thyroid-related complications.

How similar studies have gone: Prior observational studies have repeatedly shown a high prevalence of thyroid dysfunction among dialysis patients, supporting routine screening, though interventional benefits from screening are less well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years and older.
* Patients diagnosed with end-stage renal disease (ESRD) on regular hemodialysis for at least 3 months.

Exclusion Criteria:

* Known Thyroid Disorders: Patients with a history of thyroid disease (e.g., hypothyroidism, hyperthyroidism) prior to starting dialysis.
* Recent Thyroid Treatment: Patients who have received treatment for thyroid dysfunction (e.g., thyroid hormone replacement, antithyroid medications) within the last six months.
* Patients with acute kidney injury (AKI) or those who are not on regular dialysis.
* Pregnant or lactating women.
* Patients with systemic illnesses or medications that could interfere with thyroid function tests (e.g., corticosteroids, lithium).

Where it's running

  • Hospital
    Sohag, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.